Universal Ibogaine Inc announced that CEO Nick Karos will present at the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond. The event is a hybrid online and in-person event scheduled for June 27. "H.C. Wainwright is a leader in the space and could be a strong strategic partner in our ongoing corporate finance roadmap,” Karos said in a statement. “The opportunity to tell our story to this audience is another important step in developing the awareness around brand and offering.
Revive Therapeutics Ltd has announced that the US Food & Drug Administration (FDA) accepted the company’s Data Access Plan (DAP) submission for a Phase 3 trial of Bucillamine in patients with COVID-19. The company previously received positive comments from the FDA on its request to determine and agree on new primary efficacy endpoints for the study. Now that the DAP submission has been accepted, the company will unblind the pre-dose selection data to potentially support the amended study protocol with the new endpoints.The proposed new primary efficacy endpoints may include the rate of sustained clinical resolution of symptoms of Covid-19, which the company says addresses the shift in clinical outcomes observed over the course of the pandemic. The hope is to have more meaningful study endpoints for the FDA to consider for potential Emergency Use Authorization.
TNR Gold Corp has issued an update on the Los Azules Copper Project in San Juan, Argentina, in which it holds a 0.4% net smelter returns (NSR) royalty. The project is held by McEwen Copper Inc, a subsidiary of McEwen Mining. On Thursday, McEwen Copper offered a progress report this week on the Los Azules project highlighting three drill holes. Hole AZ22146 intersected 330 meters (m) of 0.83% copper, including 103.4 m of 1.31% copper; hole AZ22149 intersected 298 m of 0.55% copper, including 54.0 m of 1.38% copper; and hole AZ22158 intersected 176 m of 1% copper, including 44.0 m of 1.38% copper.
Paradigm Capital said it has added Plurilock Security Inc to the second edition of its Technology Watch List, one of six Canadian technology companies added that the broker's analysts believe offer attractive and emerging growth opportunities. Specifically, on Plurilock, the Paradigm analysts noted that the company has a strong customer roster with compliance in place (SOC 2) to operate as a reliable and trusted third-party vendor to government and financial institutions. "We believe the company’s customer wins are demonstrative of the effectiveness of its strategy. As software revenue scales to be a larger portion of the business it can carry higher valuations for the overall company," they concluded.
Water Tower Research said it has published a management series report on ProStar Holdings Inc which can be accessed via the following link: https://www.watertowerresearch.com/content/pointman-offers-10x-cost-savings-by-nearly-eliminating-strikes
Ortho Regenerative Technologies Inc has reported its financial results and highlights for the first quarter ended April 30, 2022. Among the key highlights for the period, the company entered a material transfer agreement with an undisclosed, industry-leading, global strategic medical company for the exclusive use of their proprietary platelet-rich plasma system in its ORTHO-R rotator cuff tear repair, phase I/II US clinical trial. "Ortho delivered important milestones during the first quarter of (FY)2023. We signed a material transfer agreement with a global company, closed an oversubscribed private placement and secured key patents that will protect our core IP for many years to come,” Philippe Deschamps, Ortho president and CEO said in a statement.
Therma Bright Inc said it has submitted an application to Health Canada for its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test for Point-of-Care Use (PoC). The Toronto-based company said the application includes all the updated data from the company's US Food and Drug Administration's (FDA) Emergency Use Authorization (EUA) application. "We're excited with our AcuVid Health Canada application and the prospect of approval for our unique COVID-19 rapid antigen saliva test for point-of-care (PoC)," said Rob Fia, CEO of Therma Bright, in a statement.
Guardforce AI Co. Limited said it has now closed the previously announced "transformational" cash and share acquisition of Beijing Wanjia Security System Co. Ltd (BJWJ) from Shenzhen Yeantec Co Limited for around US$8.4 million. On May 24 this year, the firm told investors it had struck two definitive agreements to acquire eight companies in China. The second deal, namely to acquire an additional seven companies from Shenzhen Kewei Robot Technology Co. Limited (Kewei), is still expected to close in the third quarter of this year. "The acquisition of a well-established integrated security solution provider in Beijing is truly transformative for Guardforce AI as it not only strengthens our foothold in Asia, but also expands our integrated security capabilities, Terence Yap, the chairman of Guardforce AI, told investors in a statement.
ImagineAR Inc has announced the signing of a reseller agreement with Blayney Partnership, a digital creative agency based in the United Kingdom. "Blayney Partnership is a forward-thinking dynamic agency that leverages advanced technology to deliver dynamic client solutions," ImagineAR CEO and founder Alen Paul Silverrstieen said in a statement. “As we focus on expanding around the world, we are optimistic (Blayney Partnership owner and creative director) Ozz Blayney and his team will create exceptional immersive experiences using the ImagineAR platform for his clients," Silverrstieen added.
Sonoro Gold Corp said it has filed a technical report titled "Updated Preliminary Economic Assessment of the Cerro Caliche Project, Sonora, Mexico” with an effective date of May 9, 2022. The updated Preliminary Economic Assessment (PEA) contemplates an optimized mine plan for an open pit, heap leach mining operation with an initial two-year production rate of 8,000 metric tonnes per day (mtpd) and an increase to 15,000 mtpd for the remaining life of the mine. Approximately 7,200 meters of additional drilling recently completed at Cerro Caliche was not included in the current mineral resource estimate and will be included in an updated resource estimate scheduled to be filed in the fall of 2022.
Sidus Space Inc announced that its CEO Carol Craig has been selected as an in-person speaker for International Space Convention (ISC) 2022 in Bursa, Turkey on September 9-11, 2022 and the 25th anniversary of World Satellite Business Week (WSBW) in Paris, France on September 12-16, 2022. The Space-as-a-Service company said the upcoming speaking opportunities are the latest examples of Sidus Space’s burgeoning role in the international space community, which recently included being selected for delegation visits from France and Turkey.
BioSig Technologies Inc has announced the pricing of its previously-announced 'best efforts' underwritten public offering of up to 4,666,667 shares of its common stock, $0.001 par value per share, at a price to the public of $0.75 per share. The gross proceeds to BioSig from this offering are expected to be $3,500,000.25, before deducting the underwriting discount and other estimated offering expenses payable by BioSig. The offering is expected to close on June 28, 2022, subject to customary closing conditions. BioSig said it intends to use the net proceeds from the offering for the continuation of commercialization activities related to the PURE EP System, including additional support for organizational development, to fund working capital, and for general corporate purposes and other capital expenditures.
South Star Battery Metals Corp said it has completed a non-brokered private placement of units for total proceeds of $1,906,990. The majority of participation in the private placement was with key institutional investors and insiders. Net proceeds from the private placement will be used for advanced materials sample preparation, commercial agreements, project finance and general working capital requirements for the company. The private placement consists of 3,467,254 units priced at a post-consolidation price of 55 cents per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share of the company at an exercise price of $1.25 per common share for a period of five years from the date of issue.
Deep-South Resources Inc has reported that, with regards to its action against Namibia's Ministry of Mines and Energy, at a hearing held on June 23, 2022, the court ordered the parties to file their Case Management report by June 27, 2022. The next Case Management hearing will be held on June 30, 2022. The Case Management hearing serves to prepare the final hearing. Several aspects can be discussed at the Case Management hearing such as the number of days required for the final hearing, any issues that are likely to facilitate a just and speedy resolution of the case or potential settlement prospects. The company said it will provide regular updates in this regard and any other matter concerning this situation.
Blue Sky Uranium Corp said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on May 24, 2022, and June 8, 2022, which will see the issue of 14 million shares at a purchase price of 15 cents per share, together with 14 million share purchase warrants to purchase 7 million shares with an exercise price of 25 cents for a three-year period with 52 placees.
Nevada Copper Corp has released the results from its 2022 annual general meeting of shareholders, held on Thursday, June 23, 2022, in Toronto. Shareholders holding a total of 225,979,047 common shares of the company were represented by proxy at the meeting, representing approximately 50.39% of the total 448,452,759 common shares outstanding as of the record date. Shareholders voted in favour of all items of business before the meeting.
Braxia Scientific Corp has announced its participation at the H.C. Wainwright Global Investment Conference from June 27-28, 2022 in New York. The company's CEO Dr Roger McIntyre will deliver two live presentations at the conference beginning with a Keynote address - Introduction to the State of Mental Healthcare - to kick off the conference on Monday, June 27 at 8.15am ET. Dr McIntyre, will also deliver a second presentation on Monday, June 27 at 4.00pm. ET providing an overview of the Braxia's business, including its progress on increasing access to novel ketamine and psychedelic treatments for patients with depression, while also expanding the clinical research infrastructure required to execute on the company's growing pipeline of registered clinical trials alongside third-party sponsors. Braxia's trials include Canada's first multi-dose psilocybin-assisted therapy trial which commenced in November 2021 and recently reported positive preliminary results. Dr McIntyre will also be available to host one-on-one meetings with institutional investors registered with H.C. Wainwright and Co.
BioHarvest Sciences Inc has invited its shareholders and the general public to join a Live Video Conference on Thursday, July 7, 2022, at 2.00pm Eastern Standard Time (11.00am Pacific Standard Time). The company's CEO Ilan Sobel will host the event, which will include coverage of Q2 sales results and a detailed progress update on the 2022 Growth Priorities, with specific focus on the VINIA scale-up progress in the USA and on the company's Cannabis market entry strategy into North America. Sobel commented: "We have reached the midpoint of 2022, which will be remembered as a transformative year in BioHarvest Science's growth. This year we have already made key additions to our leadership team and reached major scientific milestones - I am very excited to discuss our progress on the VINIA USA scale-up, to provide a high level update on strategic partnership discussions with key players in the North American Cannabis landscape, and to share my thoughts with our Bioharvest shareholder partners on how our disruptive platform technology will reshape the future of the Cannabis industry in North America." The presentation will be approximately 45 minutes, followed by a live question and answer session. All shareholders, media, and interested investors are welcome to join. All registrants will be emailed a recording of the session. Any questions regarding the event can be sent to justin@bioharvest.com. Registration is free via: https://app.livestorm.co/st-financial/q2-2022-bioharvest-sciences-shareholder-update?type=detailed
Virtual Investor Conferences (VIC), the leading proprietary investor conference series, today announced that the presentations from the June 23, 2022, Life Sciences Investor Forum are now available for on-demand viewing via the following link: https://bit.ly/3nbZJuO. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company's resource section. Companies are accepting 1x1 management meeting requests through June 28, 2022. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. To view a complete calendar of Virtual Investor Conferences, interested parties can visit: www.virtualinvestorconferences.com.